MedPath

The Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center logo
🇺🇸United States
Ownership
Subsidiary
Established
1826-01-01
Employees
5K
Market Cap
-
Website
http://www.case.edu/cancer

Feasibility of a Culturally-Specific Video Text Cessation Intervention With AA Quitline Callers

Not Applicable
Completed
Conditions
Tobacco Use Cessation
Interventions
Behavioral: Path2Quit - culturally specific text message intervention
First Posted Date
2019-04-25
Last Posted Date
2020-03-16
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
35
Registration Number
NCT03927976
Locations
🇺🇸

Case Western Reserve University, Cleveland, Ohio, United States

A Study of the Use of AirXpanders AeroForm in Patients Undergoing Post-Mastectomy Radiation Therapy

Not Applicable
Withdrawn
Conditions
Breast Cancer
Interventions
Device: AirXpanders AeroFormtissue expander
First Posted Date
2019-04-17
Last Posted Date
2019-08-13
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT03918317

Clinical Trial of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy

Not Applicable
Withdrawn
Conditions
Peripheral Neuropathy
Interventions
Other: Manual acupuncture
Other: Electro-acupuncture
First Posted Date
2019-03-19
Last Posted Date
2021-12-01
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT03881748
Locations
🇺🇸

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Not Applicable
Withdrawn
Conditions
Bladder Tumor (TURBT)
Non-muscle Invasive Bladder Cancer (NMIBC)
Interventions
Procedure: CBI
First Posted Date
2019-02-15
Last Posted Date
2022-05-11
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT03839472
Locations
🇺🇸

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Improving Sexual Health in Gynecologic Cancer Patients

Not Applicable
Terminated
Conditions
Gynecologic Cancer
Interventions
Behavioral: dedicated sexual health clinic appointment
First Posted Date
2019-02-04
Last Posted Date
2022-06-28
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
2
Registration Number
NCT03827993
Locations
🇺🇸

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Virtual Prostate Biopsy Protocol for Patients on Active Surveillance and at Risk of Prostate Cancer

Not Applicable
Withdrawn
Conditions
Prostate Cancer
Interventions
Diagnostic Test: virtual biopsy (VB) monitoring protocol
First Posted Date
2019-01-30
Last Posted Date
2022-05-20
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT03823001
Locations
🇺🇸

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC

Early Phase 1
Terminated
Conditions
Non-Small Cell Lung Cancer
Interventions
Radiation: Proton beam therapy RT
First Posted Date
2019-01-28
Last Posted Date
2024-02-15
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
7
Registration Number
NCT03818776
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach

Not Applicable
Recruiting
Conditions
Positive FIT or Stool DNA Testing Follow up
Interventions
Other: Patient navigator
First Posted Date
2019-01-28
Last Posted Date
2025-01-15
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
30
Registration Number
NCT03817905
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer

Not Applicable
Withdrawn
Conditions
Benign Prostatic Hyperplasia (BPH)
Prostate Cancer
Interventions
Device: Prostatic Urethral Lift (PUL)
First Posted Date
2019-01-25
Last Posted Date
2020-03-12
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT03817216

Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma

Phase 1
Withdrawn
Conditions
Pulmonary Metastatic Osteosarcoma (pOS)
Interventions
First Posted Date
2019-01-22
Last Posted Date
2025-01-15
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
20
Registration Number
NCT03811886
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath